These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8736879)

  • 1. Effect of extracellular matrix and growth arrest on the alkaline phosphatase activity of F9 embryonal carcinoma cells.
    Fleming JV; Hay SM; Rees WD
    Biochem Soc Trans; 1996 May; 24(2):221S. PubMed ID: 8736879
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of type I collagen in the regulation of the osteoblast phenotype.
    Shi S; Kirk M; Kahn AJ
    J Bone Miner Res; 1996 Aug; 11(8):1139-45. PubMed ID: 8854250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of laminin and fibronectin in endodermal and neural differentiation of F9 embryonal carcinoma cells.
    Wartiovaara J; Liesi P; Rechardt L
    Prog Clin Biol Res; 1984; 151():233-47. PubMed ID: 6473367
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
    Rizzino A; Crowley C
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):457-61. PubMed ID: 6244561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of extracellular matrix gradients on the haptotactic migration of F9 embryocarcinoma-derived primitive and parietal endoderm-like cells.
    Carnegie JA
    Biol Reprod; 1994 Feb; 50(2):413-20. PubMed ID: 8142558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in visceral endoderm: a comparison of mutant and wild-type F9 embryonal carcinoma cell differentiation.
    Rogers MB; Watkins SC; Gudas LJ
    J Cell Biol; 1990 May; 110(5):1767-77. PubMed ID: 1692330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substratum-growth factor collaborations are required for the mitogenic activities of activin and FGF on embryonal carcinoma cells.
    Schubert D; Kimura H
    J Cell Biol; 1991 Aug; 114(4):841-6. PubMed ID: 1869590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant F9 embryonal carcinoma cell line which undergoes incomplete differentiation in retinoic acid.
    Moore EE; Moritz EA; Mitra NS
    Cancer Res; 1985 Sep; 45(9):4387-96. PubMed ID: 2992778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell substratum modulates responses of preosteoblasts to retinoic acid.
    Traianedes K; Ng KW; Martin TJ; Findlay DM
    J Cell Physiol; 1993 Nov; 157(2):243-52. PubMed ID: 8227157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of extracellular matrix on the proliferation and differentiation of glioma cells in culture.
    Takagi M; Sugihara H; Tabuchi K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):553-8. PubMed ID: 1723167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Programmed application of extracellular matrix promotes neural differentiation of mouse embryonic stem cells].
    Shan ZY; Lei L; Chen YJ; Jin LH; Shen JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2126-30. PubMed ID: 19114337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nutrient deprivation and differentiation on the expression of growth-arrest genes (gas and gadd) in F9 embryonal carcinoma cells.
    Fleming JV; Hay SM; Harries DN; Rees WD
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):573-9. PubMed ID: 9461558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
    Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
    J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Linder S; Krondahl U; Sennerstam R; Ringertz NR
    Exp Cell Res; 1981 Apr; 132(2):453-60. PubMed ID: 7215454
    [No Abstract]   [Full Text] [Related]  

  • 15. Roles of extracellular matrix components in differentiating teratocarcinoma cells.
    Grover A; Adamson ED
    J Biol Chem; 1985 Oct; 260(22):12252-8. PubMed ID: 4044595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of laminin on the growth and differentiation of embryonal carcinoma cells in defined media.
    Rizzino A; Terranova V; Rohrbach D; Crowley C; Rizzino H
    J Supramol Struct; 1980; 13(2):243-53. PubMed ID: 7242089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction.
    Kirk MD; Kahn AJ
    J Bone Miner Res; 1995 Aug; 10(8):1203-8. PubMed ID: 8585424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoarchitectural changes during retinoic acid-induced apoptosis in F9 embryonal carcinoma cells.
    García-Sanz M; Atencia R; Pérez-Yarza G; Asumendi A; Hilario E; Arechaga J
    Int J Dev Biol; 1996; Suppl 1():195S-196S. PubMed ID: 9087758
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.
    Boylan JF; Lohnes D; Taneja R; Chambon P; Gudas LJ
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9601-5. PubMed ID: 8105479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.